Last reviewed · How we verify

NCT05114629

Biomechanics of Adaptive Rowing in Active and Inactive Manual Wheelchair Users

Completed Last updated 30 January 2023
What this trial tests

trial in Wheelchair in 15 participants. Completed in 17 August 2022.

Timeline
14 September 2021
Primary endpoint
17 August 2022
17 August 2022

Quick facts

Lead sponsorDrexel University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment15
Start date14 September 2021
Primary completion17 August 2022
Estimated completion17 August 2022
Sites1 location across United States

Conditions studied

Sponsor

Drexel University

Who can join

Adults 18 to 70, any sex, with Wheelchair or Water Sports. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is being performed to characterize the rowing stroke in active and inactive individuals who use a manual wheelchair. The investigators will be looking at muscle activity of four shoulder muscles (upper trapezius, lower trapezius, serratus anterior, and posterior deltoid) and motion of the arms, shoulder blade, and trunk during rowing. This will be done for three rowing conditions (1: adapted rowing ergometer, 2: rowing ergometer from a chair, 3: standard seated row exercise using an elastic band \[TheraBand\]). The investigators are also looking at shoulder strength, range of motion, quality of life, and community participation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wheelchair

Currently open trials in the same condition.

Other Drexel University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05114629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing